Phase III trial of cetuximab, bevacizumab, and 5-fluorouracil/leucovorin vs. FOLFOX-bevacizumab in colorectal cancer.

Autor: Saltz, Leonard, Badarinath, Suprith, Dakhil, Shaker, Bienvenu, Bryan, Harker, W Graydon, Birchfield, George, Tokaz, Laurence K, Barrera, David, Conkling, Paul R, O'Rourke, Mark A, Richards, Donald A, Reidy, Diane, Solit, David, Vakiani, Efsevia, Capanu, Marinella, Scales, Amy, Zhan, Feng, Boehm, Kristi A, Asmar, Lina, Cohn, Allen
Zdroj: Clinical Colorectal Cancer; 2012 Jun, Vol. 11 Issue 2, p101-111, 11p
Databáze: Complementary Index
Externí odkaz: